Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03338387 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Co-Feedback Action of Growth Hormone, PP and PYY on Ghrelin in Bulimia

StatusEnrolling by Invitation
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date: Dec 20, 2023 to Dec 20, 2026v11
  2. Re-verified, no change to tracked fieldsv10
  3. Study completion date: Feb 20, 2022 to Dec 20, 2023v9
  4. Study completion date: Feb 20, 2021 to Feb 20, 2022
    • Publications: 7 to 9
    v8
  5. Study completion date: Feb 20, 2020 to Feb 20, 2021v7
Show 5 earlier versionsHide 5 earlier versions
  1. Study completion date: Feb 20, 2019 to Feb 20, 2020
    • Publications: 6 to 7
    v6
  2. Study completion date: Feb 1, 2019 to Feb 20, 2019v5
  3. Study completion date: Aug 1, 2018 to Feb 1, 2019v4
  4. Study completion date: Jan 31, 2018 to Aug 1, 2018
    • Study title expanded, about 6 words
    v3
  5. Primary completion date: Jan 16, 2017 to Dec 16, 2007
    • Study completion date: Nov 30, 2017 to Jan 31, 2018
    • Study description expanded, about 11 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study evaluates the addition of Acipimox or placebo to exercise on growth hormone release and ghrelin secretion in bulimic patients and in healthy women. Two groups of participants will receive Acipimox together with exercise versus identical placebo with exercise.
Trial Details
NCT Number NCT03338387
Lead Sponsor Charles University, Czech Republic
Conditions
(from sponsor)		 Eating Disorder, Bulimia Nervosa
Related terms Bulimia Nervosa, Feeding and Eating Disorders
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov